Robert M. VanHimbergen - 23 Jan 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: EVP and CFO
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
Issuer symbol: ELAN
Transactions as of: 23 Jan 2026
Net transactions value: +$190
Form type: 4
Filing time: 27 Jan 2026, 16:27:21 UTC
Previous filing: 13 Jan 2026
Next filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
VanHimbergen Robert M	EVP and CFO	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	27 Jan 2026	0001724169

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Deferred Stock Units	Award	$190	+8	+96%	$24.40	16	23 Jan 2026	Common Stock	8		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2	Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.